Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2001 2
2002 2
2003 1
2004 2
2005 1
2007 3
2008 1
2009 3
2010 1
2011 1
2012 4
2013 10
2014 8
2015 7
2016 11
2017 11
2018 16
2019 10
2020 15
2021 19
2022 24
2023 17
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for pietro core to
Search for Pietro Coretto instead (3 results)
Coenzyme Q10 + alpha lipoic acid for chronic COVID syndrome.
Barletta MA, Marino G, Spagnolo B, Bianchi FP, Falappone PCF, Spagnolo L, Gatti P. Barletta MA, et al. Clin Exp Med. 2023 Jul;23(3):667-678. doi: 10.1007/s10238-022-00871-8. Epub 2022 Aug 22. Clin Exp Med. 2023. PMID: 35994177 Free PMC article. Review.

A FSS complete response was reached in 62 (53.5%) patients in treatment group and in two (3.5%) patients in control group. A reduction in FSS core < 20% from baseline at T1 (non-response) was observed in 11 patients in the treatment group (9.5%) and in 15 patients in th

…
A FSS complete response was reached in 62 (53.5%) patients in treatment group and in two (3.5%) patients in control group. A reduction in FS …
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, Agnello M, Agostinis P, Aguilar PV, Aguirre-Ghiso J, Airoldi EM, Ait-Si-Ali S, Akematsu T, Akporiaye ET, Al-Rubeai M, Albaiceta GM, Albanese C, Albani D, Albert ML, Aldudo J, Algül H, Alirezaei M, Alloza I, Almasan A, Almonte-Beceril M, Alnemri ES, Alonso C, Altan-Bonnet N, Altieri DC, Alvarez S, Alvarez-Erviti L, Alves S, Amadoro G, Amano A, Amantini C, Ambrosio S, Amelio I, Amer AO, Amessou M, Amon A, An Z, Anania FA, Andersen SU, Andley UP, Andreadi CK, Andrieu-Abadie N, Anel A, Ann DK, Anoopkumar-Dukie S, Antonioli M, Aoki H, Apostolova N, Aquila S, Aquilano K, Araki K, Arama E, Aranda A, Araya J, Arcaro A, Arias E, Arimoto H, Ariosa AR, Armstrong JL, Arnould T, Arsov I, Asanuma K, Askanas V, Asselin E, Atarashi R, Atherton SS, Atkin JD, Attardi LD, Auberger P, Auburger G, Aurelian L, Autelli R, Avagliano L, Avantaggiati ML, Avrahami L, Awale S, Azad N, Bachetti T, Backer JM, Bae DH, Bae JS, Bae ON, Bae SH, Baehrecke EH, Baek SH, Baghdiguian S, Bagniewska-Zadworna A, Bai H, Bai J, Bai XY, Bailly Y, Balaji KN, … See abstract for full author list ➔ Klionsky DJ, et al. Autophagy. 2016;12(1):1-222. doi: 10.1080/15548627.2015.1100356. Autophagy. 2016. PMID: 26799652 Free PMC article. No abstract available.
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia.
Casirati G, Cosentino A, Mucci A, Salah Mahmoud M, Ugarte Zabala I, Zeng J, Ficarro SB, Klatt D, Brendel C, Rambaldi A, Ritz J, Marto JA, Pellin D, Bauer DE, Armstrong SA, Genovese P. Casirati G, et al. Nature. 2023 Sep;621(7978):404-414. doi: 10.1038/s41586-023-06496-5. Epub 2023 Aug 30. Nature. 2023. PMID: 37648862 Free PMC article.
A 3-Year Course Of Bulevirtide Monotherapy May Cure Hdv Infection In Cirrhotics.
Anolli MP, Degasperi E, Allweiss L, Sangiovanni A, Maggioni M, Scholtes C, Oberhardt V, Neumann-Haefelin C, Dandri M, Zoulim F, Lampertico P. Anolli MP, et al. J Hepatol. 2023 Jan 3:S0168-8278(22)03475-4. doi: 10.1016/j.jhep.2022.12.023. Online ahead of print. J Hepatol. 2023. PMID: 36931396
In the off-therapy liver biopsy, intrahepatic HDV RNA and Hepatitis D antigen were undetectable, <1% hepatocytes were Hepatitis B surface antigen positive while hepatitis B core antigen was negative. Grading and staging improved compared to pre-treatment biopsy....
In the off-therapy liver biopsy, intrahepatic HDV RNA and Hepatitis D antigen were undetectable, <1% hepatocytes were Hepatitis B surface …
Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference.
Ghany MG, Buti M, Lampertico P, Lee HM; 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference Faculty. Ghany MG, et al. J Hepatol. 2023 Nov;79(5):1254-1269. doi: 10.1016/j.jhep.2023.06.002. Epub 2023 Jun 21. J Hepatol. 2023. PMID: 37377088 Review.
Suitable candidates for phase II/III trials would be treatment-naiive or experienced patients with quantifiable HDV RNA. Novel biomarkers (hepatitis B core-related antigen [HBcrAg] and HBV RNA) remain exploratory, while nucleos(t)ide analogs and pegylated interferon still …
Suitable candidates for phase II/III trials would be treatment-naiive or experienced patients with quantifiable HDV RNA. Novel biomarkers (h …
Physical clinical care and artificial-intelligence-guided core resistance training improve endurance and patient-reported outcomes in subjects with lower back pain.
Bates NA, Huffman A, Goodyear E, Nagai T, Rigamonti L, Breuer L, Holmes BD, Schilaty ND. Bates NA, et al. Clin Biomech (Bristol, Avon). 2023 Mar;103:105902. doi: 10.1016/j.clinbiomech.2023.105902. Epub 2023 Feb 15. Clin Biomech (Bristol, Avon). 2023. PMID: 36805199 Clinical Trial.
The Training cohort received supervised artificial-intelligence-guided core-focused resistance training while the Clinical group received clinical care. ...The Control group did not show significant improvements in any outcome measures. INTERPRETATION: The present data ind …
The Training cohort received supervised artificial-intelligence-guided core-focused resistance training while the Clinical group rece …
Multi-functional vesicles for cancer therapy: The ultimate magic bullet.
Tavano L, Muzzalupo R. Tavano L, et al. Colloids Surf B Biointerfaces. 2016 Nov 1;147:161-171. doi: 10.1016/j.colsurfb.2016.07.060. Epub 2016 Jul 29. Colloids Surf B Biointerfaces. 2016. PMID: 27500359 Review.
Liposomes and niosomes are nanovesicles that contain amphiphilic molecules arranged in concentric bilayers, delimitating an aqueous core. These vesicular carriers are very versatile, since they can be differently designed and modified in such a way that they exhibit combin …
Liposomes and niosomes are nanovesicles that contain amphiphilic molecules arranged in concentric bilayers, delimitating an aqueous core …
Object-Centric Scene Representations Using Active Inference.
Van de Maele T, Verbelen T, Mazzaglia P, Ferraro S, Dhoedt B. Van de Maele T, et al. Neural Comput. 2024 Mar 21;36(4):677-704. doi: 10.1162/neco_a_01637. Neural Comput. 2024. PMID: 38457764
Representing a scene and its constituent objects from raw sensory data is a core ability for enabling robots to interact with their environment. ...
Representing a scene and its constituent objects from raw sensory data is a core ability for enabling robots to interact with their e …
Peritumoral Microenvironment in High-Grade Gliomas: From FLAIRectomy to Microglia-Glioma Cross-Talk.
Altieri R, Barbagallo D, Certo F, Broggi G, Ragusa M, Di Pietro C, Caltabiano R, Magro G, Peschillo S, Purrello M, Barbagallo G. Altieri R, et al. Brain Sci. 2021 Feb 6;11(2):200. doi: 10.3390/brainsci11020200. Brain Sci. 2021. PMID: 33561993 Free PMC article. Review.
Cellular composition and molecular signatures of the glioma core compared with infiltrative margins are different, and it is well known that the tumor edge is enriched in microglia. ...
Cellular composition and molecular signatures of the glioma core compared with infiltrative margins are different, and it is well kno …
The effectiveness of clinic versus home-based, artificial intelligence-guided therapy in patients with low back pain: Non-randomized clinical trial.
Alzouhayli K, Schilaty ND, Nagai T, Rigamonti L, McPherson AL, Holmes B, Bates NA. Alzouhayli K, et al. Clin Biomech (Bristol, Avon). 2023 Oct;109:106069. doi: 10.1016/j.clinbiomech.2023.106069. Epub 2023 Aug 12. Clin Biomech (Bristol, Avon). 2023. PMID: 37717557 Clinical Trial.
METHODS: This is a non-randomized controlled trial of 51 patients (28 female, 23 male). The investigation compared an 8-week, core-focused exercise intervention in a Clinic (supervised) versus Home (unsupervised) setting. ...
METHODS: This is a non-randomized controlled trial of 51 patients (28 female, 23 male). The investigation compared an 8-week, core-fo …
162 results